Literature DB >> 19095488

Recurrence interval affects survival after local relapse of oral cancer.

Thomas Mücke1, Stefan Wagenpfeil, Marco R Kesting, Frank Hölzle, Klaus-Dietrich Wolff.   

Abstract

The aim of this study was to investigate whether the recurrence interval influenced survival rate of patients with relapse of oral squamous cell carcinoma (OSCC). From 1992 to 2006, a total of 773 patients with OSCC treated at the Department of Oral and Maxillofacial Plastic Surgery of the Ruhr-University Bochum were reviewed. Statistical analysis included descriptive statistics, Kaplan-Meier survival analyses, receiver operating characteristic, the Youden-Index and analysis using the log-rank test and Cox-regression. The overall recurrence rate was 23.9%. Local recurrence was more common (64.9%) than locoregional recurrence (25.1%). Patients with relapse more than 18 months after completion of their primary treatment had significantly improved survival rates compared with those who relapsed within 18 months of initial treatment (20.5% vs 42.3%). A significant difference was noted in the survival rate between patients with local and locoregional recurrence (37.5% vs 21.5%). Overall survival rate after salvage was 31.9%. The interval from initial treatment to recurrence is an independent prognostic factor for OSCC patients. Patients with a recurrence interval of 18 months had a statistically significant higher probability of death than those with a recurrence interval >18 months. This information can help inform salvage treatment strategies and provide a classification of early and late recurrences.

Entities:  

Mesh:

Year:  2008        PMID: 19095488     DOI: 10.1016/j.oraloncology.2008.10.011

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  27 in total

1.  Functional outcome after different oncological interventions in head and neck cancer patients.

Authors:  Thomas Mücke; Janett Koschinski; Stefan Wagenpfeil; Klaus-Dietrich Wolff; Anastasios Kanatas; David A Mitchell; Herbert Deppe; Marco R Kesting
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-06       Impact factor: 4.553

2.  Tumor thickness as an independent risk factor of early recurrence in oral cavity squamous cell carcinoma.

Authors:  Fábio Roberto Pinto; Leandro Luongo de Matos; Filipe Cavalcanti Palermo; Marco Aurélio Vamondes Kulcsar; Beatriz Godói Cavalheiro; Evandro Sobroza de Mello; Venâncio Avancini Ferreira Alves; Cláudio Roberto Cernea; Lenine Garcia Brandão
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-27       Impact factor: 2.503

3.  Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma.

Authors:  Liang Ding; Bing Li; Ying Zhao; Yi-Fu Fu; Er-Ling Hu; Qin-Gang Hu; Yan-Hong Ni; Ya-Yi Hou
Journal:  Tumour Biol       Date:  2014-07-25

4.  The role of tumor invasion into the mandible of oral squamous cell carcinoma.

Authors:  Thomas Mücke; Frank Hölzle; Stefan Wagenpfeil; Klaus-Dietrich Wolff; Marco Kesting
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-31       Impact factor: 4.553

5.  Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, Canada.

Authors:  Ian Cromwell; Dean A Regier; Stuart J Peacock; Catherine F Poh
Journal:  Oncologist       Date:  2016-07-11

6.  Influence of tumor volume on survival in patients with oral squamous cell carcinoma.

Authors:  Thomas Mücke; David A Mitchell; Lucas M Ritschl; Andrea Tannapfel; Klaus-Dietrich Wolff; Marco R Kesting; Denys J Loeffelbein; Anastasios Kanatas
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-26       Impact factor: 4.553

7.  Clinical impact of PET/CT imaging after adjuvant therapy in patients with oral cavity squamous cell carcinoma.

Authors:  Huan-Chun Lin; Chung-Jan Kang; Shiang-Fu Huang; Hung-Ming Wang; Chien-Yu Lin; Li-Yu Lee; Chun-Ta Liao; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-05-26       Impact factor: 9.236

8.  Survivorship Challenges and Information Needs after Radiotherapy for Oral Cancer.

Authors:  Hoda Badr; Daniella Lipnick; Vishal Gupta; Brett Miles
Journal:  J Cancer Educ       Date:  2017-12       Impact factor: 2.037

9.  Management of recurrent head and neck cancer: variables related to salvage surgery.

Authors:  Laura Gañán; Montserrat López; Jacinto García; Eduard Esteller; Miquel Quer; Xavier León
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-05-17       Impact factor: 2.503

10.  Autofluorescence imaging in recurrent oral squamous cell carcinoma.

Authors:  Martin Scheer; Juliana Fuss; Mehmet Ali Derman; Matthias Kreppel; Jörg Neugebauer; Daniel Rothamel; Uta Drebber; Joachim E Zoeller
Journal:  Oral Maxillofac Surg       Date:  2015-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.